Belgian regulatory structure for medicinal cannabis — FAMHP and magistral preparation
Regulatory Structure Verified 2026-04-20
Workflow steps
FAMHP — Federal Agency for Medicines and Health Products (AFMPS/FAGG)
Primary regulator for all medicines including cannabis. Issues import authorizations, EU-GMP certificates, and manages the magistral preparation framework. Belgium is EEA — FAMHP is a major EU-GMP issuing authority and significant pharma manufacturing hub.
Per-shipment import authorizations
EU-GMP certification (EEA authority)
Wholesale dealer authorizations
Magistral preparation oversight
Pharmacovigilance
Ministry of Health — Policy oversight
Sets national medicinal cannabis policy. Oversees FAMHP. Belgium permits cannabis access via authorized products (Sativex) and magistral preparation — a significant access pathway.
A SIGNIFICANT access pathway in Belgium. Pharmacists compound preparations from imported cannabis flower or extract under FAMHP-approved magistral preparation formulas. This is distinct from standard dispensing — the pharmacist is the manufacturer.
Licensed pharmacist with magistral preparation authorization
FAMHP-approved preparation formula
Cannabis sourced from FAMHP-authorized imports only
GDP and magistral preparation GMP compliance
Patients — End recipients
Access via standard prescription (Sativex) or magistral preparation. Named-patient authorization (ATU-equivalent) also available. Belgium's magistral preparation pathway provides broader access than many EU countries.